This site is intended for health professionals only

NICE: Annual drug review for people with ADHD

New guidelines have been released to improve the quality of care for children, young people and adults with attention deficit hyperactivity disorder (ADHD). 

People with ADHD who are taking a drug treatment should have a specialist review at least once per year to assess their need, the National Institute for Health and Care Excellence (NICE) have said. 

Although ADHD symptoms are often identified in children and young people by a GP or teacher, they should be referred to a specialist for assessment, NICE has suggested. The recommendations state that there are a number of potential side effects associated with ADHD drug treatment, meaning it should be regularly monitored. 

Adults with symptoms of ADHD who have not been diagnosed as a child should also be referred to a specialist, including a full clinical and psychosocial assessment of multiple aspects of the person's life. 

NICE also suggests parent training programmes for carers of children with symptoms of ADHD, which can help improve the relationship between parents of carers and their children, as well as improve the child's behaviour. 

Professor Gillian Leng, deputy chief executive and director of health and social care at NICE said: “ADHD can affect learning, behaviour and development in children, and for adults with the disorder it can be associated with forgetfulness, mood swings, and extreme impatience. This quality standard outlines how to deliver the very best care and support for both adults and children with the condition.”